Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease

Background Sleep disturbances and excessive daytime sleepiness (EDS) are common non-motor symptoms in patients with Parkinson's disease (PD). The purpose of this study was to identify the contributors to sleep disturbances, including insomnia, restless legs syndrome, rapid eye movement sleep behavior disorder (RBD), sleep-disordered breathing, nocturnal akinesia and EDS, in patients with PD. Methods We conducted a cross-sectional study including 128 consecutive Japanese patients with PD. Sleep disturbances and EDS were defined as a PD Sleep Scale-2 (PDSS-2) total score ≥15 and an Epworth Sleepiness Scale (ESS) score >10, respectively. The patients were divided into four groups according to the presence or absence of sleep disturbances and EDS. We evaluated the disease severity, motor symptoms, cognition, olfactory test, the Scales for Outcomes in PD-Autonomic dysfunction (SCOPA-AUT), the Beck Depression Inventory-II (BDI-II), and the RBD Screening Questionnaire Japanese version (RBDSQ-J). Results Of 128 patients, 64 had neither EDS nor sleep disturbances, 29 had sleep disturbances without EDS, 14 had EDS without sleep disturbances, and 21 had both EDS and sleep disturbances. Patients with sleep disturbances had higher BDI-II scores than those without sleep disturbances. Probable RBD was more frequent in patients with both sleep disturbances and EDS than in those with neither EDS nor sleep disturbances. The SCOPA-AUT score was lower in patients with neither EDS nor sleep disturbances than in patients in the other three groups. Using multivariable logistic regression analysis with neither sleep disturbances nor EDS as a reference group, that the SCOPA-AUT score was an independent contributor to sleep disturbances (adjusted OR, 1.192; 95% CI, 1.065–1.333; P = 0.002) or EDS (OR, 1.245; 95% CI, 1.087–1.424; P = 0.001) and that the BDI-II (OR, 1.121; 95% CI, 1.021–1.230; P = 0.016) and RBDSQ-J scores (OR, 1.235; 95% CI, 1.007–1.516; P = 0.043) as well as the SCOPA-AUT score (OR, 1.137; 95% CI, 1.006–1.285; P = 0.040) were independent contributors to both sleep disturbances and EDS. Conclusions Autonomic symptoms were associated with patients with sleep disturbances or EDS, and depressive and RBD symptoms in addition to autonomic symptoms were associated with patients with both sleep disturbances and EDS.

[1]  U. Kang,et al.  Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes , 2022, npj Parkinson's Disease.

[2]  Keisuke Suzuki,et al.  Sleep and Autonomic Manifestations in Parkinson’s Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder , 2022, Frontiers in Neuroscience.

[3]  G. Laux Parkinson and depression: review and outlook , 2022, Journal of Neural Transmission.

[4]  M. Sommerauer,et al.  Clinical and imaging evidence of brain-first and body-first Parkinson's disease , 2022, Neurobiology of Disease.

[5]  B. Tang,et al.  Characteristics of Autonomic Dysfunction in Parkinson’s Disease: A Large Chinese Multicenter Cohort Study , 2021, Frontiers in Aging Neuroscience.

[6]  Keisuke Suzuki Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review , 2021, Journal of Parkinson's disease.

[7]  A. Fasano,et al.  Sleep disturbance in movement disorders: insights, treatments and challenges , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  K. Hirata,et al.  Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson’s disease: A multicenter cross-sectional study , 2021, PloS one.

[9]  H. Shang,et al.  Excessive daytime sleepiness in Parkinson's disease: A systematic review and meta-analysis. , 2021, Parkinsonism & related disorders.

[10]  K. Sakimura,et al.  A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice , 2020, The Journal of Neuroscience.

[11]  Can-Xing Yuan,et al.  Multiple comorbid sleep disorders adversely affect quality of life in Parkinson’s disease patients , 2020, NPJ Parkinson's disease.

[12]  B. Mollenhauer,et al.  Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide , 2020, Movement disorders clinical practice.

[13]  A. Schapira,et al.  Parkinson disease , 2019, European journal of neurology.

[14]  H. Berendse,et al.  Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease , 2019, Journal of Neural Transmission.

[15]  Kwang-Soo Lee,et al.  Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson’s disease , 2019, Neurological Sciences.

[16]  K. Hirata,et al.  Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson’s Disease , 2018, European Neurology.

[17]  M. Politis,et al.  REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease , 2018, Neurology.

[18]  Chun-Feng Liu,et al.  Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management , 2018, Chinese medical journal.

[19]  E. Benarroch,et al.  Neuropathology of autonomic dysfunction in synucleinopathies , 2018, Movement disorders : official journal of the Movement Disorder Society.

[20]  W. Ondo,et al.  Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder , 2017, Translational Neurodegeneration.

[21]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[22]  A. Dagher,et al.  Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression , 2017, Brain : a journal of neurology.

[23]  K. Hirata,et al.  Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson’s Disease and Atypical Parkinsonian Syndromes , 2016, PloS one.

[24]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[25]  C. Adler,et al.  REM sleep behavior disorder and neuropathology in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[26]  O. Tysnes,et al.  Development of excessive daytime sleepiness in early Parkinson disease , 2015, Neurology.

[27]  K. Hirata,et al.  Evaluation of cutoff scores for the Parkinson's disease sleep scale‐2 , 2015, Acta neurologica Scandinavica.

[28]  H. Sasaki,et al.  Reliability of the Japanese version of the scales for outcomes in Parkinson's disease-autonomic questionnaire , 2014, Clinical Neurology and Neurosurgery.

[29]  O. Lins,et al.  Daytime Sleepiness in Parkinson's Disease: Perception, Influence of Drugs, and Mood Disorder , 2014, Sleep disorders.

[30]  P. Marik,et al.  Narrative Review , 2012, Journal of intensive care medicine.

[31]  K. Hirata,et al.  Nocturnal disturbances and restlessness in Parkinson's disease: Using the Japanese version of the Parkinson's disease sleep scale-2 , 2012, Journal of the Neurological Sciences.

[32]  Yuki Ideno,et al.  Evaluation of a Japanese version of the Mini‐Mental State Examination in elderly persons , 2012, Geriatrics & gerontology international.

[33]  Yuichi Inoue,et al.  The REM sleep behavior disorder screening questionnaire: validation study of a Japanese version. , 2009, Sleep medicine.

[34]  S. Fukuhara,et al.  Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory. , 2009, Sleep medicine.

[35]  Saho Ayabe-Kanamura,et al.  Development of a smell identification test using a novel stick-type odor presentation kit. , 2006, Chemical senses.

[36]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[37]  Dag Aarsland,et al.  Depression in Parkinson disease—epidemiology, mechanisms and management , 2011, Nature Reviews Neurology.

[38]  K. Hirata,et al.  Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease. , 2009, Parkinsonism & related disorders.

[39]  Reiner Labitzke,et al.  Review and Outlook , 2000 .